enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 4
Filing Date: 03 Feb 2026Report Date: 30 Jan 2026
Accepted: 03 Feb 2026 02:13 p.m.
Accession Number: 0000929638-26-000484
File Number: None
Film Number: None